Suchergebnisse - "Van Tassell, Benjamin"

PubPharm (39)

1

Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarction

enthalten in: Minerva cardiology and angiology | 2024

von Corna, G. | Golino, M. | Talasaz, A. | +13

2

Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction

enthalten in: The American journal of cardiology | 2023

von Corna, G. | Golino, M. | Moroni, F. | +13

3

Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction

enthalten in: The Journal of pharmacology and experimental therapeutics | 2023

von Del Buono, M. | Damonte, J. | Moroni, F. | +10

4

Interleukin-1 Blockade in Cardiac Sarcoidosis : A Pilot Study

enthalten in: Circulation. Arrhythmia and electrophysiology | 2023

von Kron, J. | Crawford, T. | Bogun, F. | +19

5

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction : results from a pooled analysis of the VCUART clinical trials

enthalten in: European heart journal. Cardiovascular pharmacotherapy | 2022

von Abbate, A. | Wohlford, G. | Del Buono, M. | +8

6

Targeting the NLRP3 inflammasome in cardiovascular diseases

enthalten in: Pharmacology & therapeutics | 2022

von Toldo, S. | Mezzaroma, E. | Buckley, L. | +5

7

Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure

enthalten in: The American journal of cardiology | 2022

von Mihalick, V. | Wohlford, G. | Talasaz, A. | +12

8

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2) : a randomized, double blind, placebo controlled, single center, phase 2 study

enthalten in: Journal of translational medicine | 2022

von Van Tassell, B. | Mihalick, V. | Thomas, G. | +15

9

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

enthalten in: Journal of translational medicine | 2022

von Van Tassell, B. | Mihalick, V. | Thomas, G. | +15

10

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

enthalten in: Journal of translational medicine | 2022

von Van Tassell, B. | Mihalick, V. | Thomas, G. | +15